NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Oslo University Hospital
Oslo University Hospital
BioAtla, Inc.
Epkin
Memorial Sloan Kettering Cancer Center
Pfizer
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Eastern Cooperative Oncology Group
Boehringer Ingelheim
Tracon Pharmaceuticals Inc.
Washington University School of Medicine
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Children's Oncology Group
Brown University
Brown University
Maria Sklodowska-Curie National Research Institute of Oncology
Mayo Clinic
Celgene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Novartis
Assistance Publique - Hôpitaux de Paris
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Sarcoma Alliance for Research through Collaboration
Dermatologic Cooperative Oncology Group